Formulations including 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide

Powder formulations for use in dry powder inhalers and methods of making them are provided. A powder formulation can include from about 0.01% to about 90% by weight of a carboxamide compound comprising 5-[3-(3-Hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenyl-hexanamide or a pharmaceutically acce...

Full description

Saved in:
Bibliographic Details
Main Authors MARCELLIN, Claire, BURROWS, Jane, MAGEE, Gavin
Format Patent
LanguageEnglish
Published 02.02.2023
Subjects
Online AccessGet full text

Cover

Loading…